506
Views
0
CrossRef citations to date
0
Altmetric
Hemodialysis and Peritoneal Dialysis

Calculated plasma volume status in hemodialysis patients

, &
Article: 2322685 | Received 05 Jan 2024, Accepted 19 Feb 2024, Published online: 27 Feb 2024

References

  • de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1–7. doi:10.1001/jama.2009.1488.
  • Hecking M, Schmiedecker M, Waller M, et al. Active fluid management in tassin/France of the 21st century and outcomes. Kidney Int. 2022;102(6):1427–1428. doi:10.1016/j.kint.2022.09.010.
  • Loutradis C, Sarafidis PA, Ferro CJ, et al. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management. Nephrol Dial Transplant. 2021;36(12):2182–2193. doi:10.1093/ndt/gfaa182.
  • Hecking M, Madero MM, Port FK, et al. Fluid volume management in hemodialysis: never give up!. Kidney Int. 2023;103(1):2–5. doi:10.1016/j.kint.2022.09.021.
  • Tangvoraphonkchai K, Davenport A. Pre-dialysis and post-dialysis hydration status and N-terminal pro-brain natriuretic peptide and survival in haemodialysis patients. Int J Artif Organs. 2016;39(6):282–287. doi:10.5301/ijao.5000514.
  • Kim EJ, Choi MJ, Lee JH, et al. Extracellular fluid/intracellular fluid volume ratio as a novel risk indicator for all-cause mortality and cardiovascular disease in hemodialysis patients. PLoS One. 2017;12(1):e0170272. doi:10.1371/journal.pone.0170272.
  • Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30(10):1257–1269. doi:10.1016/j.medengphy.2008.06.009.
  • Covic A, Ciumanghel AI, Siriopol D, et al. Value of bioimpedance analysis estimated “dry weight” in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49(12):2231–2245. doi:10.1007/s11255-017-1698-4.
  • Ling HZ, Flint J, Damgaard M, et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail. 2015;17(1):35–43. doi:10.1002/ejhf.193.
  • Grodin JL, Philips S, Mullens W, et al. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. Eur J Heart Fail. 2019;21(5):634–642. doi:10.1002/ejhf.1407.
  • Tamaki S, Yamada T, Morita T, et al. Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure-a prospective comparative study with other indices of plasma volume. Circ Rep. 2019;1(9):361–371. doi:10.1253/circrep.CR-19-0039.
  • Martens P, Nijst P, Dupont M, et al. The optimal plasma volume status in heart failure in relation to clinical outcome. J Card Fail. 2019;25(4):240–248. doi:10.1016/j.cardfail.2018.11.019.
  • Maznyczka AM, Barakat MF, Ussen B, et al. Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery. Heart. 2019;105(13):1020–1026. doi:10.1136/heartjnl-2018-314246.
  • Shimura T, Yamamoto M, Yamaguchi R, et al. Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement. ESC Heart Fail. 2021;8(3):1990–2001. doi:10.1002/ehf2.13270.
  • He C, Zhang S, He H, et al. Predictive value of plasma volume status for contrast-induced nephropathy in patients with heart failure undergoing PCI. ESC Heart Fail. 2021;8(6):4873–4881. doi:10.1002/ehf2.13681.
  • Hakim RM. Plasmapheresis. In Daugirdas JT, Blake PG, Ing TS, eds. Handbook of dialysis., 3rd ed. Philadelphia: lippincott, Williams and Wilkins; 2001. p236.
  • Longo D. Table 218: body fluids and other mass data. In Longo DL, Fauci AS,Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison’s principles of internal medicine., 18th edn. New York: mcGraw-Hill; 2011. p.A-1.
  • Chamney PW, Wabel P, Moissl UM, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85(1):80–89. doi:10.1093/ajcn/85.1.80.
  • Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28(8):2491–2497. doi:10.1681/ASN.2016121341.
  • Hur E, Usta M, Toz H, et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61(6):957–965. doi:10.1053/j.ajkd.2012.12.017.
  • Ohashi Y, Sakai K, Hase H, et al. Dry weight targeting: the art and science of conventional hemodialysis. Semin Dial. 2018;31(6):551–556. doi:10.1111/sdi.12721.
  • Fairbanks VF, Klee GG, Wiseman GA, et al. Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. Blood Cells Mol Dis. 1996;22(2):169–186. doi:10.1006/bcmd.1996.0024.
  • Moissl UM, Wabel P, Chamney PW, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006;27(9):921–933. doi:10.1088/0967-3334/27/9/012.
  • Ng YY, Hung YN, Wu SC, et al. Progression in comorbidity before hemodialysis initiation is a valuable predictor of survival in incident patients. Nephrol Dial Transplant. 2013;28(4):1005–1012. doi:10.1093/ndt/gfs512.
  • Can Ö, Bilek G, Sahan S. Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic. Int Urol Nephrol. 2022;54(3):661–669. doi:10.1007/s11255-021-02926-3.
  • Tang J, Wang L, Luo J, et al. Early albumin level and mortality in hemodialysis patients: a retrospective study. Ann Palliat Med. 2021;10(10):10697–10705. doi:10.21037/apm-21-2611.
  • Otaki Y, Watanabe T, Konta T, et al. Impact of calculated plasma volume status on all-cause and cardiovascular mortality: 4-year nationwide community-based prospective cohort study. PLoS One. 2020;15(8):e0237601. doi:10.1371/journal.pone.0237601.
  • Miller WL. Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail. 2016;9(8):e002922. doi:10.1161/CIRCHEARTFAILURE.115.002922.
  • Weiner DE, Brunelli SM, Hunt A, et al. Improving clinical outcomes among hemodialysis patients: a proposal for a “volume first” approach from the chief medical officers of US dialysis providers. Am J Kidney Dis. 2014;64(5):685–695. doi:10.1053/j.ajkd.2014.07.003.